# Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma

> **NCT00975741** · PHASE3 · COMPLETED · sponsor: **Mantecorp Industria Quimica e Farmaceutica Ltd.** · enrollment: 97 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** OXIMAX
- **DEVICE:** ASMANEX TWISTHALER

## Key facts

- **NCT ID:** NCT00975741
- **Lead sponsor:** Mantecorp Industria Quimica e Farmaceutica Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2009-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00975741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00975741, "Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00975741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*